Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with

Updated on: April 07,2024

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with

Updated on:April 07,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on: January 16,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on:January 16,2024

Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers

by Johns Hopkins University School of MedicineJ1568 study treatment schema.Eligible patients with clinically resectable PDA received the first priming study treatment Cy-GVAX-based therapy (alone

Updated on: January 30,2024

Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers

by Johns Hopkins University School of MedicineJ1568 study treatment schema.Eligible patients with clinically resectable PDA received the first priming study treatment Cy-GVAX-based therapy (alone

Updated on:January 30,2024

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache

Updated on: April 28,2024

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache

Updated on:April 28,2024

Wide variation in bowel cancer rates after colonoscopies in England

by British Medical JournalBowel cancer survivor John Barnes. Credit: University of LeedsSubstantial variation exists between colonoscopy providers in rates of bowel cancer up to three years after

Updated on: May 11,2024

Wide variation in bowel cancer rates after colonoscopies in England

by British Medical JournalBowel cancer survivor John Barnes. Credit: University of LeedsSubstantial variation exists between colonoscopy providers in rates of bowel cancer up to three years after

Updated on:May 11,2024

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no

Updated on: January 04,2024

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no

Updated on:January 04,2024

Using math to better treat cancer

by University of WaterlooGraphical abstract. Credit:Journal of Mathematical Biology(2022). DOI: 10.1007/s00285-022-01819-yResearchers at the University of Waterloo have identified a n

Updated on: January 28,2024

Using math to better treat cancer

by University of WaterlooGraphical abstract. Credit:Journal of Mathematical Biology(2022). DOI: 10.1007/s00285-022-01819-yResearchers at the University of Waterloo have identified a n

Updated on:January 28,2024

Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum

Updated on: May 21,2024

Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum

Updated on:May 21,2024

Researchers discover marker that may show when a type of skin cancer is preparing to metastasize

by Center for Genomic RegulationFrom left to right: Noemí Haro, Óscar Pozo, Inma Hernández-Muñoz, Evelyn Andrades, Paloma Torres & Ramon Pujol. Credit: Hospital de Mar/IMIMCells that form cutaneou

Updated on: February 20,2024

Researchers discover marker that may show when a type of skin cancer is preparing to metastasize

by Center for Genomic RegulationFrom left to right: Noemí Haro, Óscar Pozo, Inma Hernández-Muñoz, Evelyn Andrades, Paloma Torres & Ramon Pujol. Credit: Hospital de Mar/IMIMCells that form cutaneou

Updated on:February 20,2024

Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with

Updated on: December 30,2023

Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with

Updated on:December 30,2023

Study shows how morphine may contribute to bone loss and cancer-induced bone pain

by Stacy Pigott,University of ArizonaOn the left, cells isolated from breast cancer cells were treated with RANKL, a growth factor that stimulates bone resorption, to produce osteoclasts (pink).

Updated on: January 22,2024

Study shows how morphine may contribute to bone loss and cancer-induced bone pain

by Stacy Pigott,University of ArizonaOn the left, cells isolated from breast cancer cells were treated with RANKL, a growth factor that stimulates bone resorption, to produce osteoclasts (pink).

Updated on:January 22,2024

Scientists develop potential stealth cancer therapy

by Yale Cancer Center/Smilow Cancer HospitalCredit:ACS Central Science(2024). DOI: 10.1021/acscentsci.4c00559Sneaking by cancer's defenses, by disguising tumor-fighting antibodies insi

Updated on: July 17,2024

Scientists develop potential stealth cancer therapy

by Yale Cancer Center/Smilow Cancer HospitalCredit:ACS Central Science(2024). DOI: 10.1021/acscentsci.4c00559Sneaking by cancer's defenses, by disguising tumor-fighting antibodies insi

Updated on:July 17,2024